{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnswerDate=2019-06-04&tablingMemberConstituency=Bolton+West&min-AnswerDate=2019-06-04", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?AnswerDate=2019-06-04&tablingMemberConstituency=Bolton+West&min-AnswerDate=2019-06-04", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnswerDate=2019-06-04&tablingMemberConstituency=Bolton+West&min-AnswerDate=2019-06-04&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&AnswerDate=2019-06-04&tablingMemberConstituency=Bolton+West&min-AnswerDate=2019-06-04", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnswerDate=2019-06-04&tablingMemberConstituency=Bolton+West&min-AnswerDate=2019-06-04", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnswerDate=2019-06-04&tablingMemberConstituency=Bolton+West&min-AnswerDate=2019-06-04", "items" : [{"_about" : "http://data.parliament.uk/resources/1128437", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1128437/answer", "answerText" : {"_value" : "<p>The National Institute for Health and Care Excellence takes into account the availability of medicines through the Early Access to Medicines Scheme (EAMS) in terms of scheduling its assessments, however the process followed in assessing the technology is the same as for non-EAMS technologies.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
        }
        , "answeringMemberConstituency" : {"_value" : "South Ribble"}
        , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
        , "dateOfAnswer" : {"_value" : "2019-06-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-06-07T14:54:05.017Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-05-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether (a) NICE and (b) NHS England take into account the availability of medicines under the Early Access to Medicines Scheme when assessing those same medicines for approval as new medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4398", "label" : {"_value" : "Biography information for Chris Green"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bolton West"}
      , "tablingMemberPrinted" : [{"_value" : "Chris Green"}
      ], "uin" : "257759"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}